PACTR202109562160747已完成未知
PCT2DMEP
Wachemo University research and community vice president0 个研究点目标入组 200 人开始时间: 2021年9月9日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19 Year(s) 至 44 Year(s)（—）
- 性别
- All
入选标准
- •If they were aged 18 years or older
- •Treated at WUNEMMCS Hospital and diagnosed with type 2 diabetes at least 6 months previously,
- •Took at least 1 prescribed medication for diabetes
- •Had regular visits for last 6 months with or without concomitant
- •Willingness to participate
排除标准
- •If they were missing visits in the previous six months
- •Not willing to participate
- •Participated in DM educational programs in the last 3 months
- •Mentally incapable to participate
- •Other types of diabetes
- •Comorbidity of cancer, organ failure, or other severe diseases
- •Unable to communicate and understand Amharic language
研究者
相似试验
进行中（未招募）
1 期
A phase Ia, dose-finding study to assess the safety and immunogenicity of an Orf virus-based COVID-19 vaccine booster (Prime-2-CoV_Beta) in healthy adultsCTIS2024-511266-36-00niversitaetsklinikum Tuebingen AöR72
招募中
1 期
A Phase 1 Study to Determine the Safety, and Pharmacokinetics of the Selective MET kinase Inhibitor, DO-2 in Patients With Advanced or Refractory Solid TumoursAdvanced or refractory solid tumoursCTIS2023-504897-39-00Deuteroncology60
进行中（未招募）
1 期
/AMedDRA version: 6.1Level: PTClassification code 10059515EUCTR2005-005631-97-ITISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI - FONDAZIONE G. PASCALE360
进行中（未招募）
1 期
A Phase 1, Multicenter, Open-Label Study of REM-422, an MYB mRNA Degrader, in Patients With Relapsed/Refractory AML or Higher-Risk MDSRelapsed/Refractory AML or Higher-Risk MDSMedDRA version: 20.0Level: LLTClassification code: 10001941Term: AML Class: 10029104MedDRA version: 20.0Level: LLTClassification code: 10068361Term: MDS Class: 10029104MedDRA version: 20.0Level: LLTClassification code: 10066572Term: AML progression Class: 10029104CTIS2023-510479-72-00Remix Therapeutics Inc.100
进行中（未招募）
不适用
/AMedDRA version: 14.1Level: LLTClassification code 10062357Term: SIRSSystem Organ Class: 10018065 - General disorders and administration site conditionsMedDRA version: 14.1Level: LLTClassification code 10040072Term: SepticaemiaSystem Organ Class: 10021881 - Infections and infestationsEUCTR2012-000748-81-FIJohanna Hästbacka